Remdesivir Races Through EU Review

 
• By Neena Brizmohun

Gilead Sciences’ remdesivir could get the nod from the European Medicines Agency this week as a treatment for COVID-19, paving the way for swift EU approval.

Drug remdesivir for covid 19 coronavirus treatment
The EMA is assessing Gilead's marketing application for remdesivir • Source: Shutterstock

More from Product Reviews

More from Pink Sheet